NM_001127208.3:c.3251A>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001127208.3(TET2):​c.3251A>C​(p.Gln1084Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0033 in 1,614,184 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1084H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0029 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 10 hom. )

Consequence

TET2
NM_001127208.3 missense

Scores

4
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 1.58

Publications

24 publications found
Variant links:
Genes affected
TET2 (HGNC:25941): (tet methylcytosine dioxygenase 2) The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
TET2-AS1 (HGNC:41125): (TET2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003145367).
BP6
Variant 4-105237193-A-C is Benign according to our data. Variant chr4-105237193-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 135306.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00293 (446/152354) while in subpopulation AMR AF = 0.00392 (60/15306). AF 95% confidence interval is 0.00313. There are 0 homozygotes in GnomAd4. There are 250 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TET2NM_001127208.3 linkc.3251A>C p.Gln1084Pro missense_variant Exon 3 of 11 ENST00000380013.9 NP_001120680.1 Q6N021-1A0A158SIU0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TET2ENST00000380013.9 linkc.3251A>C p.Gln1084Pro missense_variant Exon 3 of 11 5 NM_001127208.3 ENSP00000369351.4 Q6N021-1

Frequencies

GnomAD3 genomes
AF:
0.00293
AC:
446
AN:
152236
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0101
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00286
AC:
718
AN:
250770
AF XY:
0.00280
show subpopulations
Gnomad AFR exome
AF:
0.000678
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00947
Gnomad NFE exome
AF:
0.00361
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00334
AC:
4883
AN:
1461830
Hom.:
10
Cov.:
34
AF XY:
0.00321
AC XY:
2338
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.00233
AC:
104
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86256
European-Finnish (FIN)
AF:
0.00824
AC:
440
AN:
53406
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00375
AC:
4165
AN:
1111990
Other (OTH)
AF:
0.00243
AC:
147
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
313
626
938
1251
1564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00293
AC:
446
AN:
152354
Hom.:
0
Cov.:
32
AF XY:
0.00336
AC XY:
250
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41580
American (AMR)
AF:
0.00392
AC:
60
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.0101
AC:
107
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68038
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00340
Hom.:
4
Bravo
AF:
0.00259
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00395
AC:
34
ExAC
AF:
0.00264
AC:
320

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Jun 04, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.029
.;T;T;T;.
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.25
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.60
T;T;T;.;T
M_CAP
Benign
0.0089
T
MetaRNN
Benign
0.0031
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;.;L;L;.
PhyloP100
1.6
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-2.4
N;N;N;N;N
REVEL
Benign
0.099
Sift
Uncertain
0.0070
D;D;D;D;D
Sift4G
Benign
0.34
T;T;T;T;T
Polyphen
0.37
B;D;B;B;.
Vest4
0.17
MVP
0.33
MPC
0.086
ClinPred
0.043
T
GERP RS
1.4
Varity_R
0.28
gMVP
0.23
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75056899; hg19: chr4-106158350; COSMIC: COSV104597611; API